Arterys, an AI-powered medical imaging platform for radiologists, raised $28 million in Series C financing.
The company plans to use the new funds to develop its web-based medical imaging platform that leverages deep learning and cloud supercomputing to automate medical image analysis.
Benslie Investment Group and Temasek Holdings, co-led the financing round with participation from Revelation Partners, Fosun, Emergent Medical Partners, and Varian Medical Systems.
The Arterys cloud platform supports a variety of imaging modalities, including MRI and CT. It provides a solid foundation for seamless image interpretation with artificial intelligence tools, case sharing, and automated reporting. The platform is designed to capture user edits on the machine learning results so that algorithms can be improved based on real-world use. Working together, these capabilities enable the company to build and commercialize new product offerings.
The company has built two core products Cardio AI, an assistant for cardiovascular patients, and Arterys Lung AI, an assistant for lung nodule analysis. Its products are available to medical innovators at companies and universities around the world.
The company founded in 2016, has raised over $70 million to date, including a $30 million Series B financing round in 2017, which was led by Temasek, with participation from Northwell Health Ventures, NewYork-Presbyterian, Varian Medical Systems, GE Ventures, Fosun, DNA Capital, Emergent Medical Partners, and ORI Capital.